Harrow Health Inc

NASDAQ:HROW   3:59:54 PM EDT
8.55
+0.05 (+0.59%)
Mergers / Acquisitions

Harrow Health Acquires U.S. Commercial Rights To Four Branded Eye Drops

Published: 12/20/2021 12:19 GMT
Harrow Health Inc (HROW) - Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops.
Harrow Health Inc - Announced Its Acquisition of Exclusive U.S. Commercialization Rights of Four FDA-approved Ophthalmic Medicines From Novartis.
Harrow Health - After Close, Co & Novartis to Immediately Begin Transition Period & Novartis Will Continue to Sell Products & Transfer Net Profit to Co.
Harrow Health Inc - Under Terms of Agreement, Harrow Made a One‑time Payment of $14 Million USD at Closing.
Harrow Health Inc - Following Transition, Harrow Expects to Have Products Manufactured by Third Parties and Commercialize Products for U.S. Market.